NBIX · NASDAQ · Biotechnology

Neurocrine Biosciences (NBIX)

Develops and commercializes neuroscience and rare-disease medicines led by INGREZZA.

$143.00
After hours+0.76 (+0.53%)
At close$142.24(−1.19%)